Free tool
Diagnostics stocks
We cover 7 companies grouped under the Diagnostics theme. The median market value in the group is $296.22M. Across the group, the median move over the past trading day is +1.11%. Price change over the past year runs from −26.0% to +218.7% across the middle 80 percent of the group, with a median of +20.4%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
7 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| PSNL | Personalis, Inc. | $1.84B | Small cap | +267.02% | Nov 3, 2026 |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +7.19% | Oct 28, 2026 |
| QDEL | QuidelOrtho Corporation | $1.03B | Small cap | −45.57% | Nov 5, 2026 |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +186.48% | Nov 3, 2026 |
| OSUR | OraSure Technologies, Inc. | $260.70M | Small cap | +20.38% | Nov 4, 2026 |
| LUCD | Lucid Diagnostics Inc. | $190.95M | Small cap | −12.93% | Nov 11, 2026 |
| IMDX | Insight Molecular Diagnostics Inc. | $145.30M | Small cap | +78.31% | Nov 9, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.